NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/21/2026
Back to search
Official data from USPTO
B-XPANDER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
07/21/2026
Classification
Registered
Trademark type
Word
Nice classes
1
Filing date
04/15/2024
Registration date
07/21/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/21/2026
Last transaction
07/21/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/21/2024
First use in commerce
06/21/2024
Drawing code
4
Owner type
03
Owner location
San Diego, CA, US
Examiner
HARDY LUDLOW, TARAH KIM
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Adipogen Life Sciences, Inc.
Representatives
Benjamin Taggart Charmasson, Buchaca & Leach, LLP
Technical classification
Nice Classes
Class 1
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biochemical proteins for scientific, pre-clinical, and clinical research; Biochemical proteins for use in translational in vivo research; Biochemical proteins for use in immunotherapeutic research; Biochemical proteins for use in medical research; Bioreagents for scientific, pre-clinical, and clinical research; Bioreagents for use in translational in vivo research; Bioreagents for use in immunotherapeutic research; Bioreagents for use in medical research
Publications
History of USPTO decisions and trademark events.
27 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/21/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/29/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/29/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/26/2026
IUAF
USE AMENDMENT FILED
06/25/2026
EISU
TEAS STATEMENT OF USE RECEIVED
06/25/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/25/2026
EX2G
SOU EXTENSION 2 GRANTED
02/24/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/24/2026
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
01/08/2026
NREV
NOTICE OF REVIVAL - E-MAILED
01/08/2026
PETG
PETITION TO REVIVE-GRANTED
01/08/2026
PROA
TEAS PETITION TO REVIVE RECEIVED
01/08/2026
EXT2
SOU EXTENSION 2 FILED
01/07/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/08/2025
EX1G
SOU EXTENSION 1 GRANTED
07/08/2025
EXT1
SOU EXTENSION 1 FILED
07/07/2025
EEXT
SOU TEAS EXTENSION RECEIVED
07/07/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/07/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/26/2024
PUBO
PUBLISHED FOR OPPOSITION
11/26/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/20/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/01/2024
DOCK
ASSIGNED TO EXAMINER
10/29/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/27/2024
NWAP
NEW APPLICATION ENTERED
04/15/2024
Continuous trademark protection
Get notified about every new filing that threatens B-XPANDER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.